I was originally raised as en experimental Biochemist. My PhD research centered on the biochemical characterization of the soluble hydrogenase of the hyperthermophile Pyrococcus furiosus. Eventually, the research focus broadened to include other metalloproteins from P. furiosus, which were characterized by biochemical, electrochemical and spectroscopic methods (electron paramagnetic resonance, UV-Vis spectroscopy, cofactor analysis, bioinformatics, enzymology, etc.).
After completing my PhD, I became an Assistant Professor at Universidade Fernando Pessoa (Porto, Portugal), where I am now an Associate Professor. My research focus then moved to the computational study of enzymatic and organic reaction mechanisms using quantum chemistry and molecular dynamics methods.
I have been an Academic Editor for PeerJ since September 2015, and Section Editor for its "Biochemistry, Biophysics and Molecular Biology" section since its creation in February 2018.
Dr. Rajesh Kumar Singh was born in 1980. He received his B. Pharmacy (2003) and M. Pharmacy (2005) from UIPS, Panjab University, Chandigarh. He completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar.
Dr. Singh’s major area of research interests are synthetic medicinal chemistry, polymer-drug conjugates for targeted delivery, Antimalarial and CNS active therapeutic agents and green chemistry approaches for chemical synthesis of pharmaceutical molecules.
Dr. Singh has over 14 years of teaching experience, guided 18 PG and 01 Ph.D. students and currently guiding 02 PhD students. He has published more than 60 peer-reviewed scientific research papers in SCI indexed various Chemistry and Pharmacy Journals of impact factor 1.5 to 4.8 as the main or corresponding author.
Dr. Singh is Editorial Board Member of SCOPUS indexed 06 Int. Journals. He has received Publon Award 2016, 2017 and Publon “Excellent Peer Reviewer award” for outstanding reviewing more than 120 research papers of different International Journals of ACS, RSC, Springer, Elsevier, Dove, Informa and Bentham of Impact Factor varies from 1.0 to 8.5. He has also to his credit more than 50 National and International Conference Abstracts, 2 Books, 5 Best Paper Presentation Awards, 1 Travel grant to attend Int. Conf. and 5 Research Projects funded by various government funding agencies.
Fletcher Jones Endowed Chair in Computational Biology and Associate Professor of Biology, University of La Verne. Member of The Russian-American Science Association Coordinating Committee.
Professor of Chemistry, and Director of the Program in Bioinformatics, Boston University. Elected Fellow of the AAAS. Recipient of the Herbert A. Sober Award of the ASBMB. Research interests include developing new chemical probe methods (in particular, hydroxyl radical footprinting) for determining the structure of DNA, RNA, and DNA-protein complexes.
Professor of Molecular Biotechnology. Director of the cluster Microbial Biotechnology & Health and vice-director of the Institute of Biology at Leiden University, The Netherlands. Guest Professor at the Netherlands Institute of Ecology (NIOO-KNAW) in Wageningen, The Netherlands. Biotech entrepreneur. Chair of the board of the International Symposium for the Biology of Actinomycetes (ISBA).
Professor of Biology in the Department of Molecular Biology, Cellular Biology, and Biochemistry at Brown University.
Professor of Biology and Director at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University; Head of Biology Department. Editor of Diversity, Biotechnology Journal and Journal of Ornithology. Member of several editorial boards and scientific societies. Author of over 20 books and over 700 original peer-reviewed publications.
Research Professor, Head of the Biodegradation Laboratory for Toxic Organic Compounds, Environmental Microbiology and Biodegradation Group, Department of Environmental Protection. Our research aims to understanding the reaction mechanisms of microbes mineralizing or detoxifying persistent toxic organics, such as dioxins, PCBs, explosives, pesticides, and other recalcitrant chemical compounds. We are elucidating catabolic pathways and optimize them genetically.
On the Editorial boards of Journal of Bacteriology (2000-2011), Applied and Environmental Microbiology (2006 - 2017). Associate (2012-2016) and Specialty Chief Editor of Frontiers in Microbiology (2016 - 12/2017); Invited Section Editor for the 2016 special issue on Environmental Biotechnology of Current Opinion in Biotechnology.
Xiaofeng Xin is a research scientist working in the Broad Technology Labs developing novel next-generation sequencing library preparation methodologies, which aim to reduce cost and input materials. He came to the Broad Institute of MIT and Harvard in 2015 after completing his postdoc at MIT, where he studied type 2 diabetes using a systems biology approach.
Xin received his Ph.D. from the University of Toronto; during the course of his doctoral studies, he worked as a visiting scientist in the Vidal Lab at the Dana-Farber Cancer Institute.
He has extensive research experience in genomics, functional genomics, systems biology, synthetic biology, molecular biology, yeast genetics, biochemistry, and bioinformatics.
I am a broadly-trained microbiologist with a research background in molecular biology, microbial ecology, genomics and biogeochemistry. Over the past 12 years I have served as a Staff Scientist within the Department of Energy National Laboratory system, first in the Environmental Biotechnology Section at Savannah River National Laboratory (2005-2011) and then in the Biosciences and Chemistry Divisions at Los Alamos National Laboratory (2011-current). As a staff scientist, I developed and managed a variety of research programs, focusing on microbial communities involved in processes relevant to climate change, fate and transport of radionuclides in the environment and bioenergy production. I received a BS degree from the University of Wyoming in Biochemistry, after which I worked as a laboratory technologist at the University of Utah and the VA medical center in Salt Lake City, UT with a team investigating the molecular underpinnings of diabetes. I received my doctorate in Cellular and Molecular Biology at Oregon State University in 2001 under Drs. Daniel Arp and Peter Bottomley investigating biodegradation of toxic compounds, such as trichloroethylene and toluene, by soil microorganisms. I completed postdoctoral training (2001-2004) at Los Alamos National Laboratory under Dr. Cheryl Kuske examining how the microorganisms that build and maintain biocrusts in soils of arid environments might respond to climate change.
I’m Project Scientist at University of California, Davis. My research interests focus on developing novel chemoenzymatic methods for efficient synthesis of biologically important complex carbohydrates and glycoconjugates; exploring substrate specificities of glycosyltransferases and other carbohydrate biosynthetic enzymes; as well as analyzing, purifying, and characterizing carbohydrates and glycoconjugates.